We have exceptional experience handling cases arising out of the biotech and pharmaceutical industries. We investigate matters such as whistleblower retaliation, falsification of GxP documents, FDA/OSHA compliance, anti-kickback compliance, off-label promotion, misappropriation of trade secrets, insider trading, conflicts of interest, ethical issues, and other Code of Conduct violations.
For more information regarding biotech and pharmaceutical company investigations, please contact Matthias Wagener at mwagener@wagenerlaw.com.